What The Study Did: Researchers document the antibody response to a second dose of Pfizer-BioNTech (BNT162b2) vaccine in a group of 117 allogeneic hematopoietic (from a donor) stem cell transplant recipients.
Authors: Patrice Chevallier, M.D., Ph.D., of Nantes University Hospital in Nantes, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.26344)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.26344?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091421
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open